[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 16, 1997

Thyroid Storm

Author Affiliations

From the Institute of Health Policy Research, University of California, San Francisco. Dr Rennie is also Deputy Editor (West), JAMA.

JAMA. 1997;277(15):1238-1243. doi:10.1001/jama.1997.03540390068038
Abstract

In this issue of THE JOURNAL, we are publishing a report1 of work that started 9 years ago, was concluded in December 1990, and the data from which were published in another journal in July 1995. Given that we at JAMA like to keep up-to-date and that we try never to republish what others have already put in print, the reader might well ask what is going on. The story necessary to answer this question provides a cautionary tale that illustrates the sharply differing views of research taken by the university researcher and the company sponsoring that research, if the company's product is at stake. At a time when an increasing proportion of research funding is provided by private companies,2 the story holds lessons for both, as well as for university faculties, administrators, regulatory agencies, and for physicians who prescribe on the basis of evidence.

See also pp

×